Abstract

Metabolic syndrome is a highly prevalent human disease with substantial genomic and environmental components. Previous studies indicate the presence of significant genetic determinants of several features of metabolic syndrome on rat chromosome 16 (RNO16) and the syntenic regions of human genome. We derived the SHR.BN16 congenic strain by introgression of a limited RNO16 region from the Brown Norway congenic strain (BN-Lx) into the genomic background of the spontaneously hypertensive rat (SHR) strain. We compared the morphometric, metabolic, and hemodynamic profiles of adult male SHR and SHR.BN16 rats. We also compared in silico the DNA sequences for the differential segment in the BN-Lx and SHR parental strains. SHR.BN16 congenic rats had significantly lower weight, decreased concentrations of total triglycerides and cholesterol, and improved glucose tolerance compared with SHR rats. The concentrations of insulin, free fatty acids, and adiponectin were comparable between the two strains. SHR.BN16 rats had significantly lower systolic (18–28 mmHg difference) and diastolic (10–15 mmHg difference) blood pressure throughout the experiment (repeated-measures ANOVA, P < 0.001). The differential segment spans approximately 22 Mb of the telomeric part of the short arm of RNO16. The in silico analyses revealed over 1200 DNA variants between the BN-Lx and SHR genomes in the SHR.BN16 differential segment, 44 of which lead to missense mutations, and only eight of which (in Asb14, Il17rd, Itih1, Syt15, Ercc6, RGD1564958, Tmem161a, and Gatad2a genes) are predicted to be damaging to the protein product. Furthermore, a number of genes within the RNO16 differential segment associated with metabolic syndrome components in human studies showed polymorphisms between SHR and BN-Lx (including Lpl, Nrg3, Pbx4, Cilp2, and Stab1). Our novel congenic rat model demonstrates that a limited genomic region on RNO16 in the SHR significantly affects many of the features of metabolic syndrome.

Highlights

  • Metabolic syndrome is defined as the clustering of several conditions in one individual, including obesity, hypertension, insulin resistance, and dyslipidemia

  • Several total genome scans conducted during derivation of the spontaneously hypertensive rat (SHR).BN16 strain excluded the presence of non-SHR alleles other than those fixed on RNO16, confirming the congenic status of the new strain

  • The new SHR.BN16 congenic model shows that a limited genomic region of RNO16 in the SHR is important for many features of metabolic syndrome

Read more

Summary

Introduction

Metabolic syndrome is defined as the clustering of several conditions in one individual, including obesity, hypertension, insulin resistance, and dyslipidemia. There is ample evidence both for genetically driven susceptibility to metabolic syndrome [3] and for the importance of lifestyle, epigenetic, and developmental factors [4]. It remains to be determined whether the hereditary component of metabolic syndrome is represented by a supercritical sum of risk alleles for the individual features of the syndrome or whether there are particular variants within perturbed metabolic and signaling networks that are specific for the transition to metabolic syndrome as a whole

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call